445 related articles for article (PubMed ID: 7649617)
1. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS.
Blakemore WF; Crang AJ; Franklin RJ; Tang K; Ryder S
Glia; 1995 Feb; 13(2):79-91. PubMed ID: 7649617
[TBL] [Abstract][Full Text] [Related]
2. Remyelination of demyelinated rat axons by transplanted mouse oligodendrocytes.
Crang AJ; Blakemore WF
Glia; 1991; 4(3):305-13. PubMed ID: 1832658
[TBL] [Abstract][Full Text] [Related]
3. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
Mothe AJ; Tator CH
Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
[TBL] [Abstract][Full Text] [Related]
4. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes.
Blakemore WF
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):1-10. PubMed ID: 15634226
[TBL] [Abstract][Full Text] [Related]
5. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain.
Targett MP; Sussman J; Scolding N; O'Leary MT; Compston DA; Blakemore WF
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):199-206. PubMed ID: 8804021
[TBL] [Abstract][Full Text] [Related]
6. Transplanted cultured type-1 astrocytes can be used to reconstitute the glia limitans of the CNS: the structure which prevents Schwann cells from myelinating CNS axons.
Blakemore WF
Neuropathol Appl Neurobiol; 1992 Oct; 18(5):460-6. PubMed ID: 1454135
[TBL] [Abstract][Full Text] [Related]
7. Lines of glial precursor cells immortalised with a temperature-sensitive oncogene give rise to astrocytes and oligodendrocytes following transplantation into demyelinated lesions in the central nervous system.
Trotter J; Crang AJ; Schachner M; Blakemore WF
Glia; 1993 Sep; 9(1):25-40. PubMed ID: 8244529
[TBL] [Abstract][Full Text] [Related]
8. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH
Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353
[TBL] [Abstract][Full Text] [Related]
9. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells.
Groves AK; Barnett SC; Franklin RJ; Crang AJ; Mayer M; Blakemore WF; Noble M
Nature; 1993 Apr; 362(6419):453-5. PubMed ID: 8464477
[TBL] [Abstract][Full Text] [Related]
10. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors.
Blakemore WF; Gilson JM; Crang AJ
Exp Neurol; 2003 Dec; 184(2):955-63. PubMed ID: 14769388
[TBL] [Abstract][Full Text] [Related]
11. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
12. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.
Zujovic V; Thibaud J; Bachelin C; Vidal M; Coulpier F; Charnay P; Topilko P; Baron-Van Evercooren A
Stem Cells; 2010 Mar; 28(3):470-9. PubMed ID: 20039366
[TBL] [Abstract][Full Text] [Related]
13. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
Tepavcević V; Blakemore WF
Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
[TBL] [Abstract][Full Text] [Related]
14. Olfactory ensheathing cells exhibit unique migratory, phagocytic, and myelinating properties in the X-irradiated spinal cord not shared by Schwann cells.
Lankford KL; Sasaki M; Radtke C; Kocsis JD
Glia; 2008 Nov; 56(15):1664-78. PubMed ID: 18551623
[TBL] [Abstract][Full Text] [Related]
15. Schwann cell remyelination is restricted to astrocyte-deficient areas after transplantation into demyelinated adult rat brain.
Shields SA; Blakemore WF; Franklin RJ
J Neurosci Res; 2000 Jun; 60(5):571-8. PubMed ID: 10820427
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter.
Franklin RJ; Bayley SA; Milner R; Ffrench-Constant C; Blakemore WF
Glia; 1995 Jan; 13(1):39-44. PubMed ID: 7751054
[TBL] [Abstract][Full Text] [Related]
17. Reconstruction of the glia limitans by sub-arachnoid transplantation of astrocyte-enriched cultures.
Franklin RJ; Blakemore WF
Microsc Res Tech; 1995 Nov; 32(4):295-301. PubMed ID: 8573779
[TBL] [Abstract][Full Text] [Related]
18. [The role of transplanted astrocytes for the regeneration of CNS axons].
Imaizumi T; Lankford KL; Kocsis JD; Hashi K
No To Shinkei; 2001 Jul; 53(7):632-8. PubMed ID: 11517487
[TBL] [Abstract][Full Text] [Related]
19. Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival.
Iwashita Y; Fawcett JW; Crang AJ; Franklin RJ; Blakemore WF
Exp Neurol; 2000 Aug; 164(2):292-302. PubMed ID: 10915568
[TBL] [Abstract][Full Text] [Related]
20. Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury.
Papastefanaki F; Chen J; Lavdas AA; Thomaidou D; Schachner M; Matsas R
Brain; 2007 Aug; 130(Pt 8):2159-74. PubMed ID: 17626035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
